N-of-One to Incorporate New AMP Guidelines on Somatic Cancer Variants into its Best-in-Class Curation and Reporting for Patient-Specific Oncology Decision Support

  • Posted by Emily Haynes
  • On September 20, 2017
  • 0 Comments
September 20, 2017, Concord, MA – N-of-One, Inc., the leader in clinical interpretation of molecular tests in oncology, is proud to announce the incorporation of the recent AMP guidelines on reporting somatic cancer variants with enhanced levels of evidence (LOE) into N-of-One’s existing curation and reporting. In December of 2016, to address the field’s need […]
Read More
BACK TO
TOP
LEARN
MORE